한약재품질표준화연구사업단 대계 ( 大薊 ) Cirsii Herba 생약연구과

Similar documents
한약재품질표준화연구사업단 금은화 ( 金銀花 ) Lonicerae Flos 생약연구과

한약재품질표준화연구사업단 고삼 ( 苦參 ) Sophorae Radix 생약연구과

한약재품질표준화연구사업단 작약 ( 芍藥 ) Paeoniae Radix 생약연구과

한약재품질표준화연구사업단 단삼 ( 丹參 ) Salviae Miltiorrhizae Radix 생약연구과

한약재품질표준화연구사업단 강활 ( 羌活 ) Osterici seu Notopterygii Radix et Rhizoma 생약연구과

- 2 -

한약재품질표준화연구사업단 맥문동 ( 麥門冬 ) Liriopis Tuber 생약연구과


84-01.fm

환경중잔류의약물질대사체분석방법확립에 관한연구 (Ⅱ) - 테트라사이클린계항생제 - 환경건강연구부화학물질연구과,,,,,, Ⅱ 2010

Statistical Data of Dementia.

최종보고서_경기과학기술진흥원 김진규_ hwp

歯140김광락.PDF

이 발명을 지원한 국가연구개발사업 과제고유번호 G 부처명 한국환경산업기술원 연구사업명 토양지하수오염방지기술개발사업 연구과제명 시데로포아(Siderophore)의 대량생산을 통한 토양 및 지하수의 친환경 중금속 제거기술 개 발


51(2)-06.fm

82-01.fm


DBPIA-NURIMEDIA

슬라이드 1

-, BSF BSF. - BSF BSF ( ),,. BSF -,,,. - BSF, BSF -, rrna, BSF.


<C3CA3520B0FAC7D0B1B3BBE7BFEB202E687770>

(Microsoft PowerPoint - src.ppt [\300\320\261\342 \300\374\277\353] [\310\243\310\257 \270\360\265\345])


- 1 -

QbD 적용을위한품질심사해설서 ( 예시 )

<4D F736F F F696E74202D20BFEBB1E2C6F7C0E5BAD0BCAEB9FDB1B3C0B02DC7EDBCBEBFC1C5D9>

최종보고서 /

Precipitation prediction of numerical analysis for Mg-Al alloys

- 2 -

DBPIA-NURIMEDIA

연구배경및목적 연구배경 연구목적

26(1)-11(김기준).fm

ca_02.hwp

e hwp

°ø±â¾Ð±â±â

01_°íºÀÂùöKš

<BACFC7D1B3F3BEF7B5BFC7E22D3133B1C733C8A BFEB2E687770>


(2) : :, α. α (3)., (3). α α (4) (4). (3). (1) (2) Antoine. (5) (6) 80, α =181.08kPa, =47.38kPa.. Figure 1.

Title: Biacore getting started kit 를이용한 KD 값도출방법 목차 1. 실험목적 2. 실험개요와필요한시약및소모품 2.1 실험개요 2.2 필요한시약및소모품 3. 실험방법과결과 3.1 ph-scouting for pre-concentration

저작자표시 - 동일조건변경허락 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 이차적저작물을작성할수있습니다. 이저작물을영리목적으로이용할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원

개최요강

8-VSB (Vestigial Sideband Modulation)., (Carrier Phase Offset, CPO) (Timing Frequency Offset),. VSB, 8-PAM(pulse amplitude modulation,, ) DC 1.25V, [2

lastreprt(....).hwp

(Establishment and Management of Proteomics Core Facility)

review hwp

Microsoft Word - FS_ZigBee_Manual_V1.3.docx

1. 빨리 출되는 매에서 검출되는 시를 체. 이 단계에서 칼 없이 직접 검출에 연결하여 시의 검출 체. 2. 메탄올과 이 혼합된 이동상을 이하여 C18에서 시의 출을 체하고 시의 탄소 수 및 와 된 참고 참고. 3. 이동상의 메탄올 양을 변화시키면서 k 값을 2-20

- 1 -

<C7D1BDC4BFAC20B1E8B5BFBCF6B9DABBE7B4D4676C75636F20C3D6C1BE5B315D2E687770>

- 1 -

untitled

25(6)-21(김유곤).fm

Journal of Life Science 2011, Vol. 21. No μ μ

EN.qxd


(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

歯RCM

Microsoft Word - IO_2009_메모리반도체.doc

untitled

최은옥인하대학교식품영양학과 1. 1,200, %, 50%,, -linolenic acid. (linseed oil; 38%)..,, ( 1998),, (, 1998).,., -3/ -6,,,,. 433

. PC DP-1VR P15 1ch 1 Input Tool 4ch RS-232C RS-232C. Input Tool P14 MUX-10F P16 MeasureReport P21 GO/NG 2 MeasurLink Real-Time P19 MeasurLink STATMea

DBPIA-NURIMEDIA

한글사용설명서

(01) hwp

00....

책임연구기관

주관기관 냄새환경학회 국립환경과학원

목차 ⅰ ⅲ ⅳ Abstract v Ⅰ Ⅱ Ⅲ i

PDF

- 2 -

Electropure EDI OEM Presentation

84-07.fm

LC MS Chemistry

목차 1. 제품 소개 특징 개요 Function table 기능 소개 Copy Compare Copy & Compare Erase

untitled

DBPIA-NURIMEDIA

PowerPoint 프레젠테이션

Microsoft PowerPoint - d ppt [호환 모드]

033~50 ¿ŁÃ³¸® ¹×

< C6AFC1FD28B1C7C7F5C1DF292E687770>

- 1 -

(72) 발명자 장종산 대전 중구 수침로 138, 103동 204호 (태평동, 유등 마을쌍용아파트) 박용기 대전 유성구 어은로 57, 119동 302호 (어은동, 한 빛아파트) 황동원 경기 안양시 만안구 양화로147번길 7, 102동 403호 (박달동, 박달동동원베네스

<B5DEC7A5C1F628BCB1BCFBB1E82D E6169>


사용자 설명서 SERVO DRIVE (FARA-CSD,CSDP-XX)

: : : : : : : : : : : : - 1 -

한약재생리활성성분의분리및분석연구 ( 금은화, 인동 ) 서울대학교 식품의약품안전청

KR

Coriolis.hwp

- 2 -

배 시설재배 에너지 절감 및 고품질 생산기술.PDF

19(1) 02.fm

49(6)-06.fm

.

587.eps

063~078 인삼


Transcription:

한약재품질표준화연구사업단 대계 ( 大薊 ) Cirsii Herba 생약연구과

KHP Cirsii Herba Cirsium japonicum DC. var. ussuriense (regel) Kitamura - CP2015 Cirsii Japonici Herba Cirsium setosum (Willd.) MB. linarin 0.70% JP16 - - - - 2 -

α α β β - 3 -

Sample information - 4 -

- 5 -

(mg) p-hydroxybenzoic acid (1) 60 - protocatechuic acid (2) 60 - vanillic acid (3) 60 - caffeic acid (4) 60 - chlorogenic acid (5) 60 - apigenin (6) 60, luteolin (7) 1070, luteolin-7--glucopyranoside (8) 130, luteolin-5--glucopyranoside (9) 7700, pectolinarin (10) 60, lupeol (11) 85 - apigenin 7--glucuronide (12) 50 - diosmin (13) 500 - diosmetin (14) 70 - hispidulin 7--neohesperidoside (15) 150, apigenin 7--glucoside (16) 20 - - 6 -

H H (compound number) H p-hydroxybenzoic acid (1) H protocatechuic acid (2) H H vanillic acid (3) H H H caffeic acid (4) H C 2 H H H H H H chlorogenic acid (5) H apigenin (6) H H H H luteolin (7) H H H H luteolin-7--glucopyranoside (8) H H H H - 7 -

H H H luteolin-5--glucopyranoside (9) H H H H H H CH3 H CH 3 H H pectolinarin (10) H H H 3 C CH 2 CH 3 CH 3 H CH 3 lupeol (11) H H H H 3 C CH3 H H H apigenin 7--glucuronide (12) H H H H H H H H H H H H H diosmin (13) H H diosmetin (14) H H H H H H H H hispidulin 7--neohesperidoside (15) H H H H H apigenin 7--glucoside (16) H H H H - 8 -

- 9 -

μ μ μ μ μ - 10 -

Table6. TLC condition Compounds Mobile phase Detection TLC plate luteolin 5--glucoside, luteolin7--glucoside, hispidulin 7--neohesperidoside, luteolin, CHCl 3 : MeH 10% Normal (5 : 1) (Silica) pectolinarin, apigenin Table7. The optimal condition of sample preparation Extracting method Solvent Time reflux MeH 60 min μ μ μ μ μ 0.1 g pulverized sample added 1 ml MeH 60 min reflux membrane filter (0.2 μm) Aliquot 25 μl HPLC analysis (10 μl) Fig4. verall analytical procedures of extracts - 11 -

Table8. HPLC analysis condition 대계기존 HPLC 분석조건 Time(min) A (0.1 % trifluoro acetic acid) % B (ACN) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 55 60 90 10 Detector UV (254 nm) Column Agilent Edipse XD8 C18 (5 μm, 4.6 150 mm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ Device Gilson UV/VIS-151, Gilson 321 Pump, Gilson 231 XL Autosampler Fig. 5. HPLC chromatogram of MeH extract (A) and standard mixture (B). (1. luteolin 5--glucoside, 2. luteolin 7--glucoside,3. hispidulin 7--neohesperidoside, 4. luteolin, 5. pectolinarin, 6. apigenin) - 12 -

Table9. HPLC analysis condition 대계 HPLC 분석조건수정 Time(min) A (0.1 % trifluoro acetic acid) % B (ACN) % Mobile phase 0 10 90 40 35 65 Detector UV (270 nm) Column Agilent Edipse XD8 C18 (5 μm, 4.6 150 mm) Flow rate 1 ml/min Column temp. 40 Injection volume 10 μ Device Gilson UV/VIS-151, Gilson 321 Pump, Gilson 231 XL Autosampler Fig. 6. HPLC chromatogram of MeH extract (A and B) and standard mixture (C). (1. luteolin 5--glucoside, 2. luteolin 7--glucoside,3. hispidulin 7--neohesperidoside, 4. luteolin, 5. pectolinarin, 6. apigenin, MP methyparaben, PP, propylparaben) - 13 -

Fig7. Content Fig8. Pattern analysis - 14 -

α Fig9. hepatoprotective - 15 -

Fig9. Anticonvulsant effects Fig10. Memory impairment - 16 -

- 17 -

μ - 18 -

- 19 -

μ μ μ - 20 -

Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 21 -

Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ α - 22 -

- 23 -

- 24 -

( ) ( ug / g) MTT assay, N assay, luteolin 5--glucoside RS assay, ELISA assay - luteolin 7--glucoside - - hispidulin 7--neohesperidoside - - - luteolin, -. pectolinarin,, - MTT assay, N assay, RS assay, ELISA assay. apigenin MTT assay, N assay, RS assay, ELISA assay - MTT assay, N assay, RS assay, ELISA assay. - 25 -

(Cirsii Herba) - - Detector ( ) Column ( ) Shimadzuu UV/VIS SPD-20A, UV (270 nm) Agilent Eclipse XD8- C18 (5 μm, 4.6 250 mm) Folw rate ( ) 1.0 ml/min Column temperature ( ) 40 Injection volume ( ) 1.0 μl Mobile phase ( ) ACN 10 % Gradient (, B%) ACN 10 % ~ 40 %, 대계의지표성분함량은각시료들간에일련의관련 성을보이지않아패턴분석을시행할수없다. - KHP CP JP KP - linarin 0.70% - 각시료들간에일련의관련성을보이지않아패턴분석을시행할수없다. - 26 -

- 27 -

H H H H H H H - 28 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 29 -

δ δ - 30 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 31 -

No. Compound MRM transition Q1 DP FP EP CE CXP Source Tem. 1 luteolin 5--glucoside 449.2 287.0 946 6.0 370.0 5.0 35.0 10.0 400-32 -

2-33 -

H H H H H H H - 34 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 35 -

δ δ - 36 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 37 -

No. Compound MRM transition Q1 DP FP EP CE CXP Source Tem. 2 luteolin 7--glucoside 449.2 287.0 1563 96.0 370.0 6.5 29.0 10.0 400-38 -

3 hispidulin 7--neohesperidose hispidulin 7--neohesperidose - 39 -

α β H H H H H H H H H H - 40 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 41 -

- 42 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 43 -

4 luteolin luteolin - 44 -

H H H H - 45 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 46 -

δ δ - 47 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 48 -

No. Compound MRM transition Q1 DP FP EP CE CXP Source Tem. 4 luteolin 287.1 153.1 359 76.0 370.0 12.0 45.0 4.0 400-49 -

5 pectolinarin pectolinarin - 50 -

H H CH3 H CH 3 H H H H - 51 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 52 -

δ δ - 53 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 54 -

No. Compound MRM transition Q1 DP FP EP CE CXP Source Tem. 5 pectolinarin 623.3 315.1 408 51.0 370.0 8.0 37.0 10.0 400-55 -

6 apigenin apigenin - 56 -

H H H - 57 -

HPLC conditions for the analysis of Cirsii Herba. Time(min) A (ACN) % B (0.1% H 3 P 4 in H 2 ) % 0 10 90 20 35 65 Mobile phase 25 35 65 30 45 55 50 45 5510 60 90 Detector UV (254 nm) Column RP C18 (4.6 150 mm 5 μm) Flow rate 1 ml/min Column temp. 30 Injection volume 10 μ - 58 -

δ δ - 59 -

Parameters LC/MS/MS System: API 2000 coupled with Shimadzu 10Avp Column: gemini C18 150 2 mm, 3 micron Solvent system: ACN : 0.5 % Formic acid = 70 : 30 Running time: 5 min Volume injection : 20 μl Flow rate: 0.25 ml/min Ion mode: ESI positive MRM - 60 -

No. Compound MRM transition Q1 DP FP EP CE CXP Source Tem. 6 apigenin 271.6 153.1 838 76.0 370.0 12.0 43.0 4.0 400-61 -